Asensus Surgical Inc

Asensus Surgical — TransEnterix — Investor Presentation (April 2015)

29 slides from Asensus Surgical's investor presentation, Apr 21, 2015

  1. Slide 1: Analyst Investor Event

    Analyst Investor Event SAGES Conference Nashville, TN April 17, 2015 Webcast at: http://ir.transenterix.com/events.cfm Exhibit 99.1

  2. Slide 2: Forward Looking Statement

    Forward Looking Statement 2 2 Any statements contained in this presentation that do not describe historical facts, including statements about the beliefs and expectations of TransEnterix, Inc. (“TransEnterix,” "we" or "our") and other statements regarding our future plans and goals, may constitute f

  3. Slide 3: Agenda

    Agenda 3 Corporate Update – Todd M. Pope, CEO TransEnterix Surgeon Speakers – Dr. Helmuth Billy, Ventura, CA – Dr. Raymond Leveillee, Miami, FL – Dr. Juan-Carlos Verdeja, Miami, FL Q&A SurgiBot System Demo

  4. Slide 4: Powered and Robotically-enabled Next-generation Platform

    Powered and Robotically-enabled Next-generation Platform The SurgiBot System is currently in development and has not yet been cleared by the FDA for sale in the United States or by other regulatory authorities for sale outside the United States. SurgiBot TM

  5. Slide 5: Investment Highlights

    Investment Highlights 5 Focus Technology Solution Market Experience Surgical robotics Developing patient-side robotic platform: SurgiBot Addresses unmet needs in today’s robotic offerings Cost effective Broad procedure applicability Large addressable market – ~2M US procedures Strong management team

  6. Slide 6: Benefits of Surgical Robotics

    6 Improved surgeon ergonomics Benefits of Surgical Robotics Advanced visualization Improved dissection and retraction strength Enhanced precision and control Benefits of Surgical Robotics

  7. Slide 7: SurgiBot First Patient-side Robotic Platform

    SurgiBot First Patient-side Robotic Platform 7 Surgeon scrubbed-in Easily repositioned for multi- quadrant surgery Flexible, articulating channels & instruments Steerable 3DHD Small, mobile platform Cost effective platform

  8. Slide 8: SurgiBot First Patient-side Robotic Platform

    8 SurgiBot First Patient -side Robotic Platform 3DHD Optics/Cart SurgiBot System

  9. Slide 9: Procedure Market Opportunity

    9 Bariatric Surgery Cholecystectomy Colorectal Gynecology/Urology Procedure Market Opportunity Targeted US Procedures 160K 1,140K 363K 230K Source: Millennium Research Group US Markets Laparoscopic Devices 2014 ~2M US Laparoscopic Procedures

  10. Slide 10: Hospital Market Opportunity

    Hospital Market Opportunity 10 Hospitals without Robotic Capability Hospitals with Robotic Capability Current robotic offerings are not cost effective Surgery centers – untapped market for robotics Losing market share to robotic facilities Large underpenetrated OUS opportunity System price Limited p

  11. Slide 11: Significant Base of Underserved Hospitals

    Significant Base of Underserved Hospitals 11 Mid/Small Hospitals Surgery Centers >3,000 w/ <300 beds >80% lack robotic offering Losing market share to robotic facilities Represent >800K target annual procedures ~5,000 in US Economics driving rapid procedure growth SurgiBot System will offer versatil

  12. Slide 12: Combining Advanced Technology AND Maximizing Value

    Combining Advanced Technology AND Maximizing Value 12 Surgical Robotics >$2B Revenue High Growth Price Traditional Laparoscopy >$10B Revenue Low Growth

  13. Slide 13: Regulatory Update

    Regulatory Update 13 510(k) pathway Successfully completed GLP labs Low-risk testing and documentation in-process 510(k) Submission on track for mid-2015

  14. Slide 14: Surgeon Speakers

    Surgeon Speakers 14 – Helmuth Billy, MD, Ventura, CA – Raymond Leveillee, MD FRCS-G, Miami, FL – Juan-Carlos Verdeja, MD FACS, Miami, FL

  15. Slide 15: Helmuth Billy, MD

    15 Helmuth Billy, MD Ventura, CA

  16. Slide 16: General & Bariatric Surgeon

    16 General & Bariatric Surgeon Laparoscopic training at Cedars- Sinai, USC Private Practice Ventura and Oxnard, CA Primarily operate at St. John’s Regional and Community Memorial Operate at freestanding outpatient surgery center Visiting Consultant Surgeon, Hamad Hospital, Doha, Qatar 2012-present H

  17. Slide 17: MIS Practice

    17 21 years laparoscopic experience Routine laparoscopic procedures are: – Cholecystectomy – Gastric Sleeve – Gastric Bypass – Colons – Hernia repair – Appendectomy Robotic Experience: – Trained, but not currently using Helmuth Billy, MD MIS Practice

  18. Slide 18: SurgiBot System Assessment

    18 Efficient to set up and dock, keeps room turnover time low Ease of use amongst multiple ORs within a day Quick learning curve… second case was total OR time of minutes Preserves multiport lap skills already learned Eliminates need for almost any assistance Helmuth Billy, MD SurgiBot System Assess

  19. Slide 19: How SurgiBot System Fits My Practice

    19 OR Efficiency Application for broad range of general surgery procedures Reducing number of incisions is attractive to patients May consolidate significant volume to facility that acquires Helmuth Billy, MD How SurgiBot System Fits My Practice

  20. Slide 20: Raymond Leveillee, MD FRCS-G

    20 Raymond Leveillee, MD FRCS-G Miami, FL

  21. Slide 21: Urologist

    21 Urologist Trained at UMASS Medical, Brown University MIS Fellowship U of Minnesota Dept appointments in Urology, Radiology, and Biomedical Engineering Academic Medical Center University of Miami, 20+ years Past President Southeast Section of AUA Alt. Rep, AUA BOD Raymond Leveillee, MD FRCS-G Expe

  22. Slide 22: MIS Practice

    22 26 years laparoscopic experience Routine laparoscopic procedures are: – Nephrectomies – Prostatectomies – Pyeloplasties – Adrenalectomy – Reconstruction Laparoscopic and Robotic Fellowship Director 99-14 Robotic Experience: – 14 years, over 1,000 cases Raymond Leveillee, MD FRCS-G MIS Practice

  23. Slide 23: SurgiBot System Assessment

    23 Value in robotic system that keeps surgeon in sterile field Lower cost system for smaller hospitals and for benign and some malignant conditions Overcomes limitations of single port surgery Adjustable triangulation Clutching is a major benefit in improving ergonomics of single port lap surgery A

  24. Slide 24: How SurgiBot System Fits My Practice

    24 Being in sterile field for key maneuvers Value in multiple Urologic surgeries Replicates lap approach that many urologists still prefer for renal procedures Urologists eager for robotic alternatives Raymond Leveillee, MD FRCS-G How SurgiBot System Fits My Practice

  25. Slide 25: Juan-Carlos Verdeja, MD FACS

    25 Juan-Carlos Verdeja, MD FACS Miami, FL

  26. Slide 26: General Surgeon

    26 General Surgeon Trained at U of Miami Authored first report in world's literature on Laparoscopic Colon Surgery Primarily operate at three hospitals in Baptist Health South Florida Director of General Surgery Division of Baptist Health Medical Group Director of Minimally Invasive Surgery, Associa

  27. Slide 27: MIS Practice

    27 25 years laparoscopic experience, >10K cases Routine laparoscopic procedures are: – Cholecystectomy – Colectomy – Appendectomy – Hernia Repair Robotic Experience: – Nissen Fundoplication – Splenectomy – Gastrectomy Juan-Carlos Verdeja, MD FACS MIS Practice

  28. Slide 28: SurgiBot System Assessment

    28 3DHD is vital and significant benefit Being in sterile field is important Strength of flexible instruments is outstanding Maintains the best approach for single site surgery with excellent triangulation Laparoscopic motion is natural after >10K cases Juan-Carlos Verdeja, MD FACS SurgiBot System A

  29. Slide 29: How SurgiBot System Fits My Practice

    29 Can be the primary tool for single port cholecystectomy Extends approach to other procedures with additional vision and strength Opportunity at smaller hospitals and surgery centers in Baptist Health Network Juan-Carlos Verdeja, MD FACS How SurgiBot System Fits My Practice

TransEnterix — Investor Presentation (April 2015) on 6ix